DiaSorin SpA
Piergiorgio Pedron is Chief Financial Officer of the DiaSorin Group. He was born in 1971, and in 1995 he graduated in economics and business with honors from Università Cattolica, Milan.
Since 1996 he has held different financial roles at the two North American multinationals Jabil and Hewlett Packard, as well as at De Agostini Editore S.p.A., spending 2 years at the English branch as Group Controller.
In 2011, he joined DiaSorin S.p.A. as Group Controller. He subsequently spent 18 months as CFO at the North American associate DiaSorin Inc. In January 2015 he returned to Italy to take up the role of Deputy Chief Financial Officer of DiaSorin S.p.A.
This person is not in any offices
DiaSorin SpA
4 followers
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company's business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.